CytRx Issues Statement Regarding U.S. Regulatory Review of Arimoclomol for Niemann-Pick Disease Type C
LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused…
LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused…
RIVERVIEW, FL / ACCESSWIRE / December 31, 2020 / Damon Greene, founder of The Iconic Agent…
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY,AB…
NEW YORK, NY / ACCESSWIRE / December 31, 2020 / Paypolitan CEO and founder Nils…
VANCOUVER, BC / ACCESSWIRE / December 31, 2020 / ZoomAway Travel Inc. (TSXV:ZMA)(OTCQB:ZMWYF) (the “Company”…
TORONTO, ON / ACCESSWIRE / December 31, 2020 / BitRush Corp. (CSE:BRH)(FSE:0XSN) (“BitRush” or the “Company“)…
ORLANDO, FL / ACCESSWIRE / December 31, 2020 / Dedicated surfers across the United States,…
VANCOUVER, BC / ACCESSWIRE / December 31, 2020 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3)…
TORONTO, ON / ACCESSWIRE / December 31, 2020 / StageZero Life Sciences, Ltd. (TSX:SZLS) (“StageZero”…